Huma Launches Hi Scribe to Automate Clinical Documentation with AI

Huma Launches Hi Scribe to Automate Clinical Documentation with AI

Huma Therapeutics has launched Hi Scribe, a generative AI tool that automates clinical documentation and billing directly from patient–doctor conversations. The system is already live in 870 clinics across the UK and will expand globally through partnerships with governments and enterprises, including telehealth platform Wheel in the U.S.

Hi Scribe runs on Huma’s AI engine—Huma Intelligence (Hi)—and builds on insights from 60 million consultations via eConsult, acquired last year. It integrates directly into EHR systems like EMIS and SystmOne, auto-generating structured notes and billing codes in real time for both in-person and virtual care.

Related startups

The product complies with MHRA regulations and is part of Huma’s certified medical device platform. It's designed to ease administrative burdens on clinicians, with early adopters reporting time savings of 2–3 minutes per consultation and greater patient engagement.

Wheel will debut Hi Scribe in the U.S. through its Horizon platform, targeting virtual-first care delivery. Huma is also working with governments to roll out the technology nationally as part of broader healthcare digitalization efforts.

With expansion underway across 70 countries and a user base of 50 million, Hi Scribe aims to redefine clinical workflows with safe, compliant, AI-powered tools.

Sponsored content disclosure: This article contains sponsored content. Our editorial standards remain paramount — opinions, analysis, and conclusions are independent and were not dictated by the sponsor. We accept compensation for distribution and promotion, never for editorial direction. See our partner program for how sponsorships work.

© 2025 StartupHub.ai. All rights reserved. Do not enter, scrape, copy, reproduce, or republish this article in whole or in part. Use as input to AI training, fine-tuning, retrieval-augmented generation, or any machine-learning system is prohibited without written license. Substantially-similar derivative works will be pursued to the fullest extent of applicable copyright, database, and computer-misuse laws. See our terms.